The United States of America v. Gilead Sciences, Inc. et al

Track this case

Case Number:

1:19-cv-02103

Court:

Delaware

Nature of Suit:

Patent

Judge:

Maryellen Noreika

Firms

Companies

Sectors & Industries:

  1. May 15, 2020

    HHS Says Gilead Can't Allege Misconduct In HIV Drug IP Suit

    The U.S. Department of Health and Human Services urged a Delaware federal judge Friday to throw out Gilead's counterclaims against the agency in its suit accusing the drugmaker of infringing its patents for an HIV treatment, arguing it can't accuse the government of inequitable conduct in obtaining its own patents.

  2. January 24, 2020

    Gilead Says CDC Broke Promises After Taking Free HIV Drugs

    The Centers for Disease Control and Prevention took free drugs from Gilead to research HIV but then kept the resulting inventions to itself, in violation of several contracts, the drugmaker said after the government accused it of infringement.

  3. November 14, 2019

    Rare HHS Patent Suit May Impact HIV Drug Pricing, Access

    The U.S. Department of Health and Human Services made the rare decision last week to sue a drugmaker for patent infringement. Law360 looks at this uncommon case and why experts think drug pricing and access are at the heart of the new litigation.

  4. November 06, 2019

    All Work, No Pay: HHS Sues Gilead Over HIV-Prevention IP

    The U.S. Department of Health and Human Services accused Gilead Sciences Inc. on Wednesday of infringing four agency patents covering the use of HIV treatment medication to prevent infection, escalating a fight that has been brewing for months.